Dossier
Kerendia
Coverage of Kerendia in the Nexus archive.
- Finerenone Also Slows Kidney Decline in Diabetes-Free Patients
Finerenone (Kerendia) slowed kidney function decline in adults with chronic kidney disease (CKD) who do not have diabetes, according to the FIND-CKD trial. The trial demonstrated a reduced annual rate of change in estimated kidney function by month 32.